STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. OKUR
  4. [EFFECT] OnKure Therapeutics, Inc. SEC Filing

[EFFECT] OnKure Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 18, 2025
Accession Number: 0001193125-25-270150
Submission Type: POS AM
CIK: 0001637715
Company Name: OnKure Therapeutics, Inc.
File Number: 333-282792

Source: View Original Filing on SEC EDGAR

Stock OKUR logo
OnKure Therapeutics

NASDAQ:OKUR

OKUR Rankings

#5643 Ranked by Market Cap
N/A Ranked by Dividends

OKUR Latest News

Nov 6, 2025
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
Nov 4, 2025
OnKure Therapeutics to Participate in Upcoming Investor Conferences
Aug 12, 2025
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
May 6, 2025
OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
Mar 10, 2025
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

OKUR Latest SEC Filings

Nov 6, 2025
[POS AM] OnKure Therapeutics, Inc. SEC Filing
Nov 6, 2025
[S-3] OnKure Therapeutics, Inc. Shelf Registration Statement
Nov 6, 2025
[424B3] OnKure Therapeutics, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 6, 2025
[8-K] OnKure Therapeutics, Inc. Reports Material Event
Nov 6, 2025
[10-Q] OnKure Therapeutics, Inc. Quarterly Earnings Report

OKUR Stock Data

37.39M
12.15M
1.66%
87.13%
1.46%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOULDER